Clinical Trial Update: Single-Versus Multiple-dose Antimicrobial Prophylaxis for Peroral Endoscopic Myotomy in Achalasia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating single- versus multiple-dose antimicrobial prophylaxis for Peroral Endoscopic Myotomy in achalasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achalasia

Snippet

Sponsor: Asian Institute of Gastroenterology, India | Conditions: Achalasia Cardia | Phase 3 | Status: UNKNOWN